Introduction
Budemet 200 Convicap is a combination of two medicines in one inhaler. It relieves the long-term symptoms of asthma and COPD, making breathing easier. I... View More
Uses of Budemet 200 Convicap
Side effects of Budemet 200 Convicap
How to use Budemet 200 Convicap
Rotacaps must not be swallowed. Check the label for directions before use. Place the capsule at the base of rotahaler, not in the mouthpiece. Twist the ... View More
How Budemet 200 Convicap works
Budemet 200 Convicap is a combination of two medicines: Formoterol and Budesonide. Formoterol is a long-acting bronchodilator which works by relaxing th... View More
Indication
Asthma, COPD
Adult Dose
Asthma Maintenance and reliever therapy: Adults and adolescents (12 years and older) - As both maintenance and reliever therapy: Adults and adolesce... View More
Child Dose
<12 years: Safety and efficacy not established
Contraindication
Primary treatment of status asthmaticus or other acute episodes of asthma. Hypersensitivity to Budesonide, Formoterol or to Lactose.
Mode of Action
Budesonide is a corticosteroid that has mainly glucocorticoid activity. It prevents and controls inflammation by controlling the rate of protein synthei... View More
Precaution
Treatment with Budesonide and Formoterol combination should not be initiated to treat a severe exacerbation or if patients have significantly worsening ... View More
Side Effect
>10% Upper respiratory tract infection (URTI) (8-11%),Headache (7-11%),Nasopharyngitis (7-11%) 1-10% Pharyngolaryngeal pain (6-9%),Stomach discomfo... View More
Pregnancy Category Note
Pregnancy In women with poorly or moderately controlled asthma, there is increased risk of several perinatal adverse outcomes such as preeclampsia in t... View More
Interaction
Concomitant admin with CYP3A4 inhibitor e.g. itraconazole, clarithromycin, erythromycin may inhibit the metabolism of budesonide. Concurrent use with no... View More
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More